Close Menu

You may find more results for this query on our sister sites: GenomeWeb and 360Dx.

Home › About Us › Our Staff › Neil Versel

Neil Versel

Editor
Phone Number
+1-773-348-0046
Email
[email protected]
Neil Versel at Genomeweb / 360dx Neil Versel at Genomeweb / 360dx

Neil Versel is an editor at GenomeWeb. He covers the life science and healthcare informatics markets.

Articles Authored by Neil Versel

Feb 24, 2021

Syapse Plans Deeper Dive Into Large Health Systems for Data-Driven Cancer Insights

Premium

With nearly $100 million in new investments since last year, the San Francisco-based informatics firm looks to ramp up its precision oncology partnerships. 

Jul 29, 2020

Nucleai Matches Cancer Patients to Immunotherapies With AI, Image Analysis

Premium

With $6.5M in new funding, the Israeli bioinformatics startup is looking to open a US office as it builds relationships with pharma, cancer centers, and payors.

Jul 27, 2020

Oncology Informatics Firm Vidence Emerges to Supply Real-World Clinical, Genomic Data to Researchers

Premium

Formerly the data analytics division of CTCA, Vidence is supporting an immuno-oncology trial for BMS as it looks to grow its network of hospital partners.

Jun 25, 2020

Deep Lens Integrates Genetic Test Results Into Clinical Trial Prescreening

Premium

The startup has exclusively licensed an integration engine from the University of Miami to augment its VIPER platform and improve trial recruitment specifically in precision oncology.

Apr 03, 2020

Adventist Health, CancerIQ Collaboration Identifying More Patients for Guidelines-Supported Genetic Testing

Premium

The health system said that the program is encouraging patient compliance and increasing revenues and savings.

Feb 25, 2020

Epic EMR Users Begin Integrating Genomics Data for Clinical Decision Support

Premium

With EMR upgrades, Penn and Rush now have structured genomic data informing clinical decision support in their precision oncology programs, but much work remains.

Dec 06, 2019

Roche Ending Partnership With Syapse

The companies had agreed in early 2018 to collaborate on the development of technologies to support precision oncology initiatives, but Roche said "priorities" have changed.

Nov 19, 2019

Despite FDA Clearance for NantHealth Test, Benefits of TMB Biomarker Unclear

Premium

Recent studies question the clinical utility of tumor mutational burden as a biomarker for immuno-oncology response, and the FDA clearance includes no therapeutic indications.

Nov 06, 2019

Jax, Microsoft Team to Mine Medical Literature for Curating Clinical Knowledgebase

Premium

Microsoft is applying its Project Hanover AI to Jackson Laboratory's Clinical Knowledgebase to help tumor boards find appropriate therapies based on tumor mutations.

Oct 10, 2019

'Virtual' Molecular Tumor Board Cuts Turnaround Time, Boosts Trial Enrollment Rate

Premium

Informaticians from Georgetown and other major cancer centers expect their technology to bring precision oncology services to community hospitals and clinics.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.